M&T Bank Corp Purchases 325 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

M&T Bank Corp raised its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 8.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,262 shares of the biotechnology company’s stock after acquiring an additional 325 shares during the quarter. M&T Bank Corp’s holdings in Axon Enterprise were worth $2,533,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Public Sector Pension Investment Board lifted its holdings in shares of Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after purchasing an additional 500 shares during the last quarter. CIBC Asset Management Inc lifted its holdings in shares of Axon Enterprise by 9.2% during the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares during the last quarter. Axxcess Wealth Management LLC purchased a new position in shares of Axon Enterprise during the third quarter valued at approximately $814,000. Soros Capital Management LLC purchased a new position in shares of Axon Enterprise during the third quarter valued at approximately $630,000. Finally, Friedenthal Financial lifted its holdings in shares of Axon Enterprise by 961.7% during the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock valued at $808,000 after purchasing an additional 1,231 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the transaction, the director now directly owns 24,259 shares of the company’s stock, valued at $15,518,239.71. This represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 5,146 shares of company stock valued at $3,262,847. Company insiders own 6.10% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on AXON. Needham & Company LLC reiterated a “buy” rating and set a $600.00 target price on shares of Axon Enterprise in a report on Wednesday, February 26th. Barclays set a $726.00 price objective on shares of Axon Enterprise and gave the stock an “overweight” rating in a report on Thursday, February 27th. TD Cowen assumed coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective for the company. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Finally, The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $587.38.

Axon Enterprise Trading Up 5.4 %

Shares of Axon Enterprise stock opened at $526.40 on Friday. The company has a market capitalization of $40.14 billion, a P/E ratio of 136.02, a P/E/G ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The company has a fifty day moving average of $599.42 and a 200 day moving average of $529.53. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.